Add like
Add dislike
Add to saved papers

Using the Capture-Recapture Method to Estimate the Incidence of Amyotrophic Lateral Sclerosis in Beijing, China.

BACKGROUND: To assess the total, gender-related and ageing process-related incidence rates of amyotrophic lateral sclerosis (ALS) in Beijing, China. Determine whether the decreased male to female ratio among postmenopausal age groups.

METHODS: We used the 2-source capture-recapture method to estimate the incidence of ALS in Beijing. The primary and secondary data sources were from diagnostic hospitals and assisted care institutions in the same area from 2010 to 2015.

RESULTS: A total of 562 cases and 283 cases were extracted from 2 data sources, and a total of 962 patients diagnosed with ALS within the 6-year period were estimated (95% CI 883-1041). The average yearly incidence was 0.77/100,000 persons (95% CI 0.71-0.83). The female to male ratio was 1.63. The incidence was associated with age and peaked in the 55-64 year age group. There was no obvious decline in the male:female ratio among postmenopausal age groups.

CONCLUSIONS: The total incidence of ALS in Beijing is similar to international reports. The onset of ALS is not merely the result of ageing.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app